دورية أكاديمية
أعرض في EDS

Functional Diversity in Radiolabeled Nanoceramics and Related Biomaterials for the Multimodal Imaging of Tumors.

التفاصيل البيبلوغرافية
العنوان: Functional Diversity in Radiolabeled Nanoceramics and Related Biomaterials for the Multimodal Imaging of Tumors.
المؤلفون: Calatayud DG; Department of Inorganic Chemistry, Universidad Autónoma de Madrid, Madrid 28049, Spain.; Department of Electroceramics, Instituto de Cerámica y Vidrio, Madrid 28049, Spain., Lledos M; Department of Chemistry, University of Bath, Bath BA2 7AY, United Kingdom., Casarsa F; Department of Chemistry, University of Bath, Bath BA2 7AY, United Kingdom., Pascu SI; Department of Chemistry, University of Bath, Bath BA2 7AY, United Kingdom.; Centre of Therapeutic Innovations, University of Bath, Bath BA2 7AY, United Kingdom.
المصدر: ACS bio & med chem Au [ACS Bio Med Chem Au] 2023 Aug 08; Vol. 3 (5), pp. 389-417. Date of Electronic Publication: 2023 Aug 08 (Print Publication: 2023).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9918232604406676 Publication Model: eCollection Cited Medium: Internet ISSN: 2694-2437 (Electronic) Linking ISSN: 26942437 NLM ISO Abbreviation: ACS Bio Med Chem Au Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Columbus, OH : American Chemical Society, [2021]-
مستخلص: Nanotechnology advances have the potential to assist toward the earlier detection of diseases, giving increased accuracy for diagnosis and helping to personalize treatments, especially in the case of noncommunicative diseases (NCDs) such as cancer. The main advantage of nanoparticles, the scaffolds underpinning nanomedicine, is their potential to present multifunctionality: synthetic nanoplatforms for nanomedicines can be tailored to support a range of biomedical imaging modalities of relevance for clinical practice, such as, for example, optical imaging, computed tomography (CT), magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT), and positron emission tomography (PET). A single nanoparticle has the potential to incorporate myriads of contrast agent units or imaging tracers, encapsulate, and/or be conjugated to different combinations of imaging tags, thus providing the means for multimodality diagnostic methods. These arrangements have been shown to provide significant improvements to the signal-to-noise ratios that may be obtained by molecular imaging techniques, for example, in PET diagnostic imaging with nanomaterials versus the cases when molecular species are involved as radiotracers. We surveyed some of the main discoveries in the simultaneous incorporation of nanoparticulate materials and imaging agents within highly kinetically stable radio-nanomaterials as potential tracers with (pre)clinical potential. Diversity in function and new developments toward synthesis, radiolabeling, and microscopy investigations are explored, and preclinical applications in molecular imaging are highlighted. The emphasis is on the biocompatible materials at the forefront of the main preclinical developments, e.g., nanoceramics and liposome-based constructs, which have driven the evolution of diagnostic radio-nanomedicines over the past decade.
Competing Interests: The authors declare no competing financial interest.
(© 2023 The Authors. Published by American Chemical Society.)
References: J Magn Reson Imaging. 1997 Jan-Feb;7(1):258-63. (PMID: 9039625)
Int J Mol Sci. 2017 Dec 13;18(12):. (PMID: 29236059)
Contrast Media Mol Imaging. 2016 Sep;11(5):405-414. (PMID: 27377033)
Biomaterials. 2005 Jun;26(18):3995-4021. (PMID: 15626447)
Cancer Metastasis Rev. 2007 Jun;26(2):225-39. (PMID: 17440684)
J Am Chem Soc. 2007 Jun 20;129(24):7661-5. (PMID: 17530850)
Science. 2005 Jan 28;307(5709):538-44. (PMID: 15681376)
Int J Mol Sci. 2017 Jan 19;18(1):. (PMID: 28106829)
J Biomed Opt. 2013 Jul;18(7):76004. (PMID: 23843082)
Appl Radiat Isot. 2017 Apr;122:211-214. (PMID: 28187357)
Chem Soc Rev. 2006 Jun;35(6):512-23. (PMID: 16729145)
Nat Rev Drug Discov. 2021 Feb;20(2):101-124. (PMID: 33277608)
Nat Rev Cancer. 2002 Sep;2(9):683-93. (PMID: 12209157)
Angew Chem Int Ed Engl. 2019 Feb 25;58(9):2570-2579. (PMID: 29968300)
JAMA. 2012 Jun 13;307(22):2418-29. (PMID: 22610500)
Genes Dev. 2003 Mar 1;17(5):545-80. (PMID: 12629038)
Biomaterials. 2009 May;30(15):2919-28. (PMID: 19230966)
Nat Mater. 2006 Feb;5(2):118-22. (PMID: 16444262)
Pharm Res. 2016 Oct;33(10):2373-87. (PMID: 27299311)
Nanoscale Res Lett. 2021 Dec 5;16(1):173. (PMID: 34866166)
Antioxid Redox Signal. 2007 Aug;9(8):1221-35. (PMID: 17536958)
Placenta. 2017 Sep;57:60-70. (PMID: 28864020)
Small. 2007 Nov;3(11):1840-54. (PMID: 17943716)
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11394-9. (PMID: 19564622)
J Mater Chem. 2009 Jan 1;19:6258-6266. (PMID: 20593005)
Analyst. 2008 Nov;133(11):1550-5. (PMID: 18936832)
Front Pharmacol. 2015 Dec 01;6:286. (PMID: 26648870)
Chem Sci. 2020 Nov 12;11(48):12888-12917. (PMID: 34123239)
Mater Sci Eng C Mater Biol Appl. 2017 Nov 1;80:274-281. (PMID: 28866165)
Int J Nanomedicine. 2009;4:277-82. (PMID: 20011244)
Nanoscale. 2015 Sep 28;7(36):14889-96. (PMID: 26292197)
Methods Enzymol. 2004;381:335-54. (PMID: 15063685)
Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):703-12. (PMID: 22160176)
ACS Nano. 2013 Nov 26;7(11):10362-70. (PMID: 24134041)
Pharm Res. 2016 Oct;33(10):2400-10. (PMID: 27286872)
Bioconjug Chem. 2016 Feb 17;27(2):319-28. (PMID: 26172432)
FASEB J. 2010 Jun;24(6):1689-99. (PMID: 20075195)
J Nucl Med. 2016 Feb;57(2):279-84. (PMID: 26564318)
Chem Soc Rev. 2013 Oct 7;42(19):7747-62. (PMID: 23793644)
Med Oncol. 2001;18(4):243-59. (PMID: 11918451)
Angew Chem Int Ed Engl. 2008;47(15):2804-7. (PMID: 18306196)
Cancer Res. 2003 Sep 15;63(18):5838-43. (PMID: 14522907)
Circulation. 2008 Jan 22;117(3):379-87. (PMID: 18158358)
ChemNanoMat. 2018 Apr;4(4):361-372. (PMID: 29938196)
Nat Rev Drug Discov. 2008 Jul;7(7):591-607. (PMID: 18591980)
J Control Release. 2022 Jan;341:605-615. (PMID: 34896448)
ACS Nano. 2016 Nov 22;10(11):10294-10307. (PMID: 27781436)
Philos Trans A Math Phys Eng Sci. 2010 Aug 13;368(1924):3683-712. (PMID: 20603377)
ChemMedChem. 2008 Sep;3(9):1311-5. (PMID: 18613203)
CA Cancer J Clin. 2014 Jan-Feb;64(1):30-51. (PMID: 24408568)
Langmuir. 2012 Jan 31;28(4):2073-82. (PMID: 22047551)
Chem Rev. 2007 Nov;107(11):4891-932. (PMID: 17924696)
Angew Chem Int Ed Engl. 2008;47(7):1184-201. (PMID: 18092309)
Cancers (Basel). 2020 May 21;12(5):. (PMID: 32455729)
Nat Nanotechnol. 2008 Jan;3(1):12-3. (PMID: 18654442)
Sci Rep. 2017 Aug 10;7(1):7850. (PMID: 28798327)
Bioconjug Chem. 2010 Nov 17;21(11):1939-42. (PMID: 20936793)
Theranostics. 2015 Sep 01;5(11):1249-63. (PMID: 26379790)
Mater Today (Kidlington). 2011 Jul;14(7-8):330-338. (PMID: 22389583)
Oncologist. 2004;9 Suppl 5:4-9. (PMID: 15591417)
Adv Funct Mater. 2017 Feb 23;27(8):. (PMID: 28989337)
Int J Mol Sci. 2022 Mar 21;23(6):. (PMID: 35328831)
Small. 2016 Sep;12(34):4735-42. (PMID: 27199216)
J Natl Cancer Inst. 1990 Jan 3;82(1):4-6. (PMID: 1688381)
Bioconjug Chem. 2010 Apr 21;21(4):715-22. (PMID: 20353170)
J Nucl Med. 2013 Jun;54(6):861-6. (PMID: 23568366)
ACS Nano. 2013 Mar 26;7(3):2461-9. (PMID: 23383962)
Biomaterials. 2021 Feb;269:120630. (PMID: 33395580)
Nano Lett. 2006 Oct;6(10):2220-4. (PMID: 17034087)
Exp Mol Pathol. 2009 Jun;86(3):215-23. (PMID: 19186176)
J Mater Chem B. 2015 Feb 14;3(6):939-958. (PMID: 32261972)
Trends Pharmacol Sci. 2009 Nov;30(11):592-9. (PMID: 19837467)
Dalton Trans. 2011 Jun 21;40(23):6129-43. (PMID: 21225080)
Angew Chem Int Ed Engl. 2013 Sep 27;52(40):10549-52. (PMID: 23956036)
Angew Chem Int Ed Engl. 2010 Mar 22;49(13):2382-4. (PMID: 20191650)
Angew Chem Int Ed Engl. 2021 Mar 15;60(12):6230-6241. (PMID: 32959963)
Sci Rep. 2012;2:610. (PMID: 22934133)
J Magn Reson Imaging. 1997 Nov-Dec;7(6):1140-5. (PMID: 9400860)
Nucl Med Biol. 1996 Nov;23(8):957-80. (PMID: 9004284)
ACS Appl Bio Mater. 2021 Aug 16;4(8):5908-5925. (PMID: 35006909)
J Biol Chem. 1992 Jun 5;267(16):10931-4. (PMID: 1375931)
Molecules. 2011 Jul 25;16(8):6165-78. (PMID: 21788926)
Oncol Lett. 2014 Jan;7(1):195-198. (PMID: 24348847)
PLoS One. 2015 Mar 06;10(3):e0119257. (PMID: 25746677)
ACS Nano. 2014 Sep 23;8(9):9274-85. (PMID: 25133802)
Angew Chem Int Ed Engl. 2011 Jun 6;50(24):5509-13. (PMID: 21544908)
Cancer. 2014 Jul 15;120(14):2080-9. (PMID: 24752817)
ACS Nano. 2015 Aug 25;9(8):7950-9. (PMID: 26213260)
Environ Sci Technol. 2014 Jan 21;48(2):873-80. (PMID: 24341906)
Int J Nanomedicine. 2017 Apr 20;12:3281-3294. (PMID: 28458546)
Chem Commun (Camb). 2009 Jun 28;(24):3511-24. (PMID: 19521594)
Int J Nanomedicine. 2012;7:3445-71. (PMID: 22848170)
Chemistry. 2009 Sep 21;15(37):9387-93. (PMID: 19658128)
Small. 2016 Jun;12(21):2872-6. (PMID: 27106630)
J Magn Reson Imaging. 2001 Jun;13(6):882-8. (PMID: 11382948)
Nanomaterials (Basel). 2022 Jan 06;12(2):. (PMID: 35055196)
Angew Chem Int Ed Engl. 2016 May 17;55(21):6187-91. (PMID: 27071806)
Biomater Res. 2018 Aug 23;22:22. (PMID: 30155269)
Contrast Media Mol Imaging. 2009 Nov-Dec;4(6):305-11. (PMID: 19941323)
Angew Chem Int Ed Engl. 2008;47(33):6259-62. (PMID: 18613191)
Nucl Med Biol. 1997 May;24(4):319-25. (PMID: 9257330)
J Nucl Med. 2004 Jan;45 Suppl 1:4S-14S. (PMID: 14736831)
Chem Soc Rev. 2012 Feb 7;41(3):1130-72. (PMID: 21796324)
Bioconjug Chem. 2008 Jul;19(7):1496-504. (PMID: 18578485)
Oncologist. 2008;13 Suppl 3:21-6. (PMID: 18458121)
Nat Biotechnol. 2006 Oct;24(10):1211-7. (PMID: 17033654)
Eur J Gastroenterol Hepatol. 2006 Aug;18(8):863-6. (PMID: 16825902)
Biomaterials. 2010 Apr;31(11):3016-22. (PMID: 20092887)
J Control Release. 2011 Dec 20;156(3):398-405. (PMID: 21787816)
Dalton Trans. 2014 Apr 14;43(14):5535-45. (PMID: 24535647)
Colorectal Dis. 2013 Jul;15(7):807-11. (PMID: 23350992)
Nanomaterials (Basel). 2019 Sep 24;9(10):. (PMID: 31554159)
Front Chem. 2022 Apr 12;10:830133. (PMID: 35494646)
Chem Commun (Camb). 2010 Dec 21;46(47):8956-8. (PMID: 20976321)
J Nucl Med. 2008 Aug;49(8):1371-9. (PMID: 18632815)
Small. 2010 Nov 5;6(21):2427-35. (PMID: 20878633)
Nat Rev Cancer. 2004 Jun;4(6):437-47. (PMID: 15170446)
Angew Chem Int Ed Engl. 2014 Oct 27;53(44):11756-61. (PMID: 25164141)
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):285-94. (PMID: 23349231)
Small. 2015 Mar 25;11(12):1409-13. (PMID: 25418741)
Small. 2009 Feb;5(2):235-43. (PMID: 19089838)
Circulation. 2002 Nov 26;106(22):2842-7. (PMID: 12451012)
J Mater Chem B. 2015 Jul 28;3(28):5657-5672. (PMID: 32262561)
Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:1327-1341. (PMID: 27987688)
J Nucl Med. 1975 Aug;16(8):744-55. (PMID: 170385)
Dalton Trans. 2011 Jun 21;40(23):6226-37. (PMID: 21394352)
Mol Cancer. 2003 Apr 17;2:23. (PMID: 12740039)
Dalton Trans. 2018 Jul 17;47(28):9283-9293. (PMID: 29796500)
Prog Nucl Magn Reson Spectrosc. 2018 Dec;109:1-50. (PMID: 30527132)
Anal Bioanal Chem. 2011 Jan;399(1):3-27. (PMID: 20924568)
Bioconjug Chem. 2013 Feb 20;24(2):196-204. (PMID: 23272904)
Chem Rev. 2015 Oct 14;115(19):10907-37. (PMID: 26166537)
Bioconjug Chem. 2011 Dec 21;22(12):2383-9. (PMID: 22035047)
Int J Pharm. 2021 Apr 15;599:120438. (PMID: 33662472)
Nanomaterials (Basel). 2021 Nov 10;11(11):. (PMID: 34835786)
Biomaterials. 2011 Dec;32(36):9758-65. (PMID: 21920599)
Chem Rec. 2016 Jun;16(3):1380-97. (PMID: 27149900)
Circ Cardiovasc Imaging. 2013 Jul;6(4):568-73. (PMID: 23771986)
Chem Soc Rev. 2005 Feb;34(2):153-63. (PMID: 15672179)
Cytotherapy. 2009;11(1):43-51. (PMID: 18956269)
PLoS One. 2013;8(2):e57046. (PMID: 23451139)
Biomaterials. 2008 Feb;29(6):724-32. (PMID: 18006052)
Chem Soc Rev. 2013 Jan 7;42(1):77-88. (PMID: 23014776)
Biomaterials. 2014 May;35(16):4688-98. (PMID: 24613050)
Nat Nanotechnol. 2016 Aug;11(8):724-30. (PMID: 27183055)
Nat Med. 2011 Sep 18;17(10):1315-9. (PMID: 21926976)
ACS Appl Mater Interfaces. 2016 Dec 7;8(48):32667-32674. (PMID: 27934189)
Nature. 2008 Apr 3;452(7187):548-52. (PMID: 18385728)
ACS Appl Mater Interfaces. 2017 Mar 1;9(8):6782-6795. (PMID: 28164704)
Curr Top Med Chem. 2013;13(8):951-62. (PMID: 23590171)
Nanomedicine (Lond). 2013 Oct;8(10):1601-9. (PMID: 23265347)
Chem Soc Rev. 2018 Apr 23;47(8):2554-2571. (PMID: 29557435)
Nat Rev Cancer. 2011 Jun;11(6):393-410. (PMID: 21606941)
Anal Chem. 2015;87(9):4829-35. (PMID: 25853631)
Clin Orthop Relat Res. 1989 Jul;(244):7-16. (PMID: 2663291)
ACS Nano. 2013 Jan 22;7(1):500-12. (PMID: 23194247)
ACS Nano. 2021 Nov 23;15(11):16974-16981. (PMID: 34748314)
Chem Sci. 2015 Jan 1;6(1):225-236. (PMID: 28553472)
J Inorg Biochem. 2004 Nov;98(11):1874-901. (PMID: 15522415)
Chem Rev. 2012 Apr 11;112(4):2373-433. (PMID: 22204603)
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):330-8. (PMID: 19915836)
Nano Lett. 2016 Sep 14;16(9):5601-4. (PMID: 27464258)
Nanoscale. 2020 Mar 28;12(12):6603-6608. (PMID: 32181455)
Acad Radiol. 2011 Jan;18(1):20-30. (PMID: 21145026)
Heliyon. 2017 Feb 23;3(2):e00253. (PMID: 28280788)
Adv Mater. 2010 Feb 2;22(5):643-6. (PMID: 20217765)
Phys Med Biol. 2013 Jun 21;58(12):3965-77. (PMID: 23685712)
Bioconjug Chem. 2016 Apr 20;27(4):1153-64. (PMID: 27003101)
Photochem Photobiol. 2006 Mar-Apr;82(2):412-7. (PMID: 16613493)
ACS Nano. 2010 Jul 27;4(7):3689-96. (PMID: 20550178)
Gastrointest Endosc. 2011 Sep;74(3):571-2. (PMID: 21872711)
Colloids Surf B Biointerfaces. 2015 Apr 1;128:245-253. (PMID: 25707751)
Biomaterials. 2011 Oct;32(29):7191-9. (PMID: 21777977)
Nanomedicine (Lond). 2007 Feb;2(1):23-39. (PMID: 17716188)
Chem Commun (Camb). 2010 Nov 28;46(44):8442-4. (PMID: 20886175)
Int J Nanomedicine. 2016 Mar 24;11:1213-23. (PMID: 27069363)
J Nucl Med. 2013 Oct;54(10):1685-8. (PMID: 24084704)
Eur J Pharm Biopharm. 2014 Nov;88(3):730-6. (PMID: 25305584)
Bioconjug Chem. 2012 Apr 18;23(4):671-82. (PMID: 22242601)
Int J Nanomedicine. 2010 Sep 07;5:653-9. (PMID: 20856841)
Nat Med. 2008 Apr;14(4):459-65. (PMID: 18376410)
Nano Lett. 2012 Jan 11;12(1):281-6. (PMID: 22172022)
Radiology. 2001 Oct;221(1):244-50. (PMID: 11568347)
ACS Appl Bio Mater. 2021 May 17;4(5):4105-4118. (PMID: 34056563)
Molecules. 2019 Dec 27;25(1):. (PMID: 31892180)
Bioconjug Chem. 2009 Feb;20(2):397-401. (PMID: 19138113)
Assay Drug Dev Technol. 2007 Feb;5(1):127-36. (PMID: 17355205)
Chem Soc Rev. 2009 Feb;38(2):372-90. (PMID: 19169455)
Small. 2011 Jul 18;7(14):2052-60. (PMID: 21688390)
Adv Mater. 2021 Jan;33(3):e2006160. (PMID: 33296121)
تواريخ الأحداث: Date Created: 20231025 Latest Revision: 20231026
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10591303
DOI: 10.1021/acsbiomedchemau.3c00021
PMID: 37876497
قاعدة البيانات: MEDLINE
الوصف
تدمد:2694-2437
DOI:10.1021/acsbiomedchemau.3c00021